Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

Contributed by: Business Wire

Tags

Research

Infectious Diseases

Genetics

Clinical Trials

Health Technology

Stem Cells

Biotechnology

Health

Science

Other Science

Takara Bio USA, Inc.

More Like This

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases

PR Newswire associated0

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

MiLaboratories co-founders: Dmitry Chudakov, Stan Poslavsky, Dmitry Bolotin, Alexey Nechaev (Photo: Business Wire)

MiLaboratories Secures Series A, Raising Total Funding to $10 Million to Revolutionize the World of Genomic Research

(Graphic: Business Wire)

bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

PR Newswire associated0

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024